At We Care Group, we believe in providing comprehensive care and support to those affected by various types of dementia, including the less common but equally impactful Frontotemporal Dementia (FTD).
What is Frontotemporal Dementia?
FTD is a type of dementia that affects the frontal and temporal lobes of the brain, which are crucial for speech, behavior, emotions, and personality. While Alzheimer’s disease is the most common cause of dementia, affecting about six in every ten people with dementia, FTD accounts for approximately 1 in 30 cases in the UK. This translates to over 30,000 individuals living with FTD in the country.
Symptoms and Variants of FTD
The symptoms of FTD can vary significantly depending on which part of the brain is affected:
- Behavioral Variant FTD (bvFTD): This variant is marked by significant changes in emotions, mood, and behavior.
- Semantic Dementia: Individuals may struggle with the meaning of words and everyday concepts.
- Progressive Non-Fluent Aphasia: This variant involves difficulties in speaking and writing.
- FTD Associated with Motor Neurone Disease (FTD-MND): When the proteins that cause FTD build up in motor nerve cells, leading to motor neurone disease.
Onset and Causes
FTD typically develops at a younger age compared to Alzheimer’s, often between the ages of 45 and 64, but it can occur as early as 40. It is one of the most common forms of young-onset dementia, affecting people under 65.
FTD is caused by damage to nerve cells in the brain due to the abnormal accumulation of proteins such as tau, TDP-43, and FUS. These proteins clump together, impairing the function of nerve cells, which eventually leads to their death. Genetic mutations, such as those in the C9orf72 gene, are known to trigger these protein buildups in some cases.
Is FTD Inherited?
Not all cases of FTD are inherited. About 30% of individuals with FTD have a familial form of the disease. However, other genetic variants and environmental factors may also play a role in the development of FTD.
Current Treatments and Research
Unfortunately, there are no approved treatments to slow, stop, or cure FTD currently. However, research is ongoing, and some potential treatments are in clinical trials. Compared to Alzheimer’s, there are fewer clinical trials for FTD in advanced stages, but the scientific community is continually working towards better understanding and treating this condition.
How We Care Group Supports Those with FDT
At We Care Group, we provide tailored care plans for residents with FTD, focusing on their unique needs and symptoms. Our dedicated and experienced team is trained to offer compassionate support, helping residents maintain their quality of life and dignity. We also stay informed about the latest research developments to incorporate new insights into our care practices.
If you have any questions about FTD or how we can support your loved ones, please don’t hesitate to reach out to us.
